CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 81 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q1 2017$75,000
-17.6%
118,1000.0%0.00%
Q4 2016$91,000
-55.4%
118,1000.0%0.00%
Q3 2016$204,000
-4.2%
118,1000.0%0.00%
Q2 2016$213,000118,1000.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,734,149$6,609,00011.59%
Third Security, LLC 13,238,268$22,770,0001.06%
MSD Partners, L.P. 3,118,402$5,364,0000.43%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 290,000$499,0000.15%
BARD ASSOCIATES INC 93,299$160,0000.08%
FRANKLIN STREET ADVISORS INC /NC 126,000$217,0000.04%
BLAIR WILLIAM & CO/IL 1,998,886$3,438,0000.03%
HAMILTON LANE ADVISORS LLC 23,855$41,0000.02%
Sheaff Brock Investment Advisors, LLC 86,449$149,0000.02%
Rothschild Capital Partners, LLC 30,000$52,0000.02%
View complete list of SYNTHETIC BIOLOGICS INC shareholders